Multidrug and extensively drug-resistant tuberculosis from a general practice perspective

B M Yashodhara, Choo Beng Huat, Lakshmi Nagappa Naik, Shashikiran Umakanth, Manjunatha Hande, Joseph M Pappachan

Research output: Contribution to journalArticle

Abstract

Despite intensive efforts to eradicate the disease, tuberculosis continues to be a major threat to Indian society, with an estimated prevalence of 3.45 million cases in 2006. Emergence of multidrug-resistant tuberculosis has complicated eradication attempts in recent years. Incomplete and/inadequate treatment are the main causes for development of drug resistance. Directly observed therapy, short-course (DOTS) is the World Health Organization (WHO) strategy for worldwide eradication of tuberculosis, and our country achieved 100% coverage for DOTS through the Revised National Tuberculosis Control Program in 2006. For patients with multidrug-resistant tuberculosis, the WHO recommends a DOTS-Plus treatment strategy. Early detection and prompt treatment of multidrug-resistant tuberculosis is crucial to avoid spread of the disease and also because of the chances of development of potentially incurable extensively drug-resistant tuberculosis in these cases. This review discusses the epidemiologic, diagnostic, and therapeutic aspects of multidrug-resistant tuberculosis, and also outlines the role of primary care doctors in the management of this dangerous disease.

Original languageEnglish
Pages (from-to)115-22
Number of pages8
JournalInfection and Drug Resistance
Volume3
DOIs
Publication statusPublished - 2010

Fingerprint

Extensively Drug-Resistant Tuberculosis
Multidrug-Resistant Tuberculosis
Directly Observed Therapy
General Practice
Tuberculosis
Therapeutics
Disease Management
Drug Resistance
Primary Health Care

Cite this

Yashodhara, B M ; Huat, Choo Beng ; Naik, Lakshmi Nagappa ; Umakanth, Shashikiran ; Hande, Manjunatha ; Pappachan, Joseph M. / Multidrug and extensively drug-resistant tuberculosis from a general practice perspective. In: Infection and Drug Resistance. 2010 ; Vol. 3. pp. 115-22.
@article{ceba0e8332ff482bb3fffb870a2f7a86,
title = "Multidrug and extensively drug-resistant tuberculosis from a general practice perspective",
abstract = "Despite intensive efforts to eradicate the disease, tuberculosis continues to be a major threat to Indian society, with an estimated prevalence of 3.45 million cases in 2006. Emergence of multidrug-resistant tuberculosis has complicated eradication attempts in recent years. Incomplete and/inadequate treatment are the main causes for development of drug resistance. Directly observed therapy, short-course (DOTS) is the World Health Organization (WHO) strategy for worldwide eradication of tuberculosis, and our country achieved 100{\%} coverage for DOTS through the Revised National Tuberculosis Control Program in 2006. For patients with multidrug-resistant tuberculosis, the WHO recommends a DOTS-Plus treatment strategy. Early detection and prompt treatment of multidrug-resistant tuberculosis is crucial to avoid spread of the disease and also because of the chances of development of potentially incurable extensively drug-resistant tuberculosis in these cases. This review discusses the epidemiologic, diagnostic, and therapeutic aspects of multidrug-resistant tuberculosis, and also outlines the role of primary care doctors in the management of this dangerous disease.",
author = "Yashodhara, {B M} and Huat, {Choo Beng} and Naik, {Lakshmi Nagappa} and Shashikiran Umakanth and Manjunatha Hande and Pappachan, {Joseph M}",
year = "2010",
doi = "10.2147/IDR.S10743",
language = "English",
volume = "3",
pages = "115--22",
journal = "Infection and Drug Resistance",
issn = "1178-6973",
publisher = "Dove Medical Press Ltd.",

}

Multidrug and extensively drug-resistant tuberculosis from a general practice perspective. / Yashodhara, B M; Huat, Choo Beng; Naik, Lakshmi Nagappa; Umakanth, Shashikiran; Hande, Manjunatha; Pappachan, Joseph M.

In: Infection and Drug Resistance, Vol. 3, 2010, p. 115-22.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multidrug and extensively drug-resistant tuberculosis from a general practice perspective

AU - Yashodhara, B M

AU - Huat, Choo Beng

AU - Naik, Lakshmi Nagappa

AU - Umakanth, Shashikiran

AU - Hande, Manjunatha

AU - Pappachan, Joseph M

PY - 2010

Y1 - 2010

N2 - Despite intensive efforts to eradicate the disease, tuberculosis continues to be a major threat to Indian society, with an estimated prevalence of 3.45 million cases in 2006. Emergence of multidrug-resistant tuberculosis has complicated eradication attempts in recent years. Incomplete and/inadequate treatment are the main causes for development of drug resistance. Directly observed therapy, short-course (DOTS) is the World Health Organization (WHO) strategy for worldwide eradication of tuberculosis, and our country achieved 100% coverage for DOTS through the Revised National Tuberculosis Control Program in 2006. For patients with multidrug-resistant tuberculosis, the WHO recommends a DOTS-Plus treatment strategy. Early detection and prompt treatment of multidrug-resistant tuberculosis is crucial to avoid spread of the disease and also because of the chances of development of potentially incurable extensively drug-resistant tuberculosis in these cases. This review discusses the epidemiologic, diagnostic, and therapeutic aspects of multidrug-resistant tuberculosis, and also outlines the role of primary care doctors in the management of this dangerous disease.

AB - Despite intensive efforts to eradicate the disease, tuberculosis continues to be a major threat to Indian society, with an estimated prevalence of 3.45 million cases in 2006. Emergence of multidrug-resistant tuberculosis has complicated eradication attempts in recent years. Incomplete and/inadequate treatment are the main causes for development of drug resistance. Directly observed therapy, short-course (DOTS) is the World Health Organization (WHO) strategy for worldwide eradication of tuberculosis, and our country achieved 100% coverage for DOTS through the Revised National Tuberculosis Control Program in 2006. For patients with multidrug-resistant tuberculosis, the WHO recommends a DOTS-Plus treatment strategy. Early detection and prompt treatment of multidrug-resistant tuberculosis is crucial to avoid spread of the disease and also because of the chances of development of potentially incurable extensively drug-resistant tuberculosis in these cases. This review discusses the epidemiologic, diagnostic, and therapeutic aspects of multidrug-resistant tuberculosis, and also outlines the role of primary care doctors in the management of this dangerous disease.

U2 - 10.2147/IDR.S10743

DO - 10.2147/IDR.S10743

M3 - Article

C2 - 21694900

VL - 3

SP - 115

EP - 122

JO - Infection and Drug Resistance

JF - Infection and Drug Resistance

SN - 1178-6973

ER -